Christopher Missling - Jun 29, 2021 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role
President and CEO, Director
Signature
/s/ Christopher Missling
Stock symbol
AVXL
Transactions as of
Jun 29, 2021
Transactions value $
-$1,273,982
Form type
4
Date filed
7/1/2021, 09:48 PM
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVXL Common Stock Options Exercise $68.1K +51.6K +5.07% $1.32* 1.07M Jun 29, 2021 Direct
transaction AVXL Common Stock Sale -$1.34M -51.6K -4.83% $26.00 1.02M Jun 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVXL Stock Option (Right to Buy) Options Exercise $0 -51.6K -41.3% $0.00 73.4K Jun 29, 2021 Common Stock 51.6K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options subject to this grant vested over 4 years on May 8, 2015, May 8, 2016, May 8, 2017, May 8, 2018.